145 related articles for article (PubMed ID: 33426646)
1. Stroke risk reassessment and oral anticoagulant initiation in primary care patients with atrial fibrillation: A ten-year follow-up.
Bezabhe WM; Bereznicki LR; Radford J; Wimmer BC; Salahudeen MS; Garrahy E; Bindoff I; Peterson GM
Eur J Clin Invest; 2021 Jun; 51(6):e13489. PubMed ID: 33426646
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing oral anticoagulant use in patients newly diagnosed with atrial fibrillation.
Bezabhe WM; Bereznicki LR; Radford J; Wimmer BC; Curtain C; Salahudeen MS; Peterson GM
Eur J Clin Invest; 2021 May; 51(5):e13457. PubMed ID: 33222261
[TBL] [Abstract][Full Text] [Related]
3. Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program.
McIntyre WF; Conen D; Olshansky B; Halperin JL; Hayek E; Huisman MV; Lip GYH; Lu S; Healey JS
Clin Cardiol; 2018 Jun; 41(6):744-751. PubMed ID: 29546729
[TBL] [Abstract][Full Text] [Related]
4. Use of oral anticoagulants in atrial fibrillation is highly variable and only weakly associated with estimated stroke risk: cross-sectional population database study.
Dreischulte T; Barnett K; Madhok V; Guthrie B
Eur J Gen Pract; 2014 Sep; 20(3):181-9. PubMed ID: 24351017
[TBL] [Abstract][Full Text] [Related]
5. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
[TBL] [Abstract][Full Text] [Related]
6. Use of oral anticoagulation therapy in the first 3 months after the diagnosis of atrial fibrillation in Israel: A population-based study.
Kezerle L; Tsadok MA; Berliner Senderey A; Hoshen M; Leventer-Roberts M; Reges O; Leibowitz M; Haim M
J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1356-1363. PubMed ID: 32212197
[TBL] [Abstract][Full Text] [Related]
7. Quality of care in patients with atrial fibrillation in primary care: a cross-sectional study comparing clinical and claims data.
Preuss R; Chenot JF; Angelow A
Ger Med Sci; 2016; 14():Doc13. PubMed ID: 27980520
[No Abstract] [Full Text] [Related]
8. Do physicians correctly calculate thromboembolic risk scores? A comparison of concordance between manual and computer-based calculation of CHADS2 and CHA2 DS2 -VASc scores.
Esteve-Pastor MA; Marín F; Bertomeu-Martinez V; Roldán-Rabadán I; Cequier-Fillat Á; Badimon L; Muñiz-García J; Valdés M; Anguita-Sánchez M;
Intern Med J; 2016 May; 46(5):583-9. PubMed ID: 26929032
[TBL] [Abstract][Full Text] [Related]
9. Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation.
Perino AC; Fan J; Askari M; Heidenreich PA; Keung E; Raitt MH; Piccini JP; Ziegler PD; Turakhia MP
Circulation; 2019 May; 139(22):2502-2512. PubMed ID: 30880434
[TBL] [Abstract][Full Text] [Related]
10. Guideline adherence of antithrombotic treatment initiated by general practitioners in patients with nonvalvular atrial fibrillation: a Danish survey.
Brandes A; Overgaard M; Plauborg L; Dehlendorff C; Lyck F; Peulicke J; Poulsen SV; Husted S
Clin Cardiol; 2013 Jul; 36(7):427-32. PubMed ID: 23670894
[TBL] [Abstract][Full Text] [Related]
11. Can the CHA
Hung J; Kelty E; Nedkoff L; Thompson SC; Katzenellenbogen JM
Intern Med J; 2021 Apr; 51(4):600-603. PubMed ID: 33890375
[TBL] [Abstract][Full Text] [Related]
12. Oral Anticoagulant Prescription Trends, Profile Use, and Determinants of Adherence in Patients with Atrial Fibrillation.
Perreault S; de Denus S; White-Guay B; Côté R; Schnitzer ME; Dubé MP; Dorais M; Tardif JC
Pharmacotherapy; 2020 Jan; 40(1):40-54. PubMed ID: 31758592
[TBL] [Abstract][Full Text] [Related]
13. Profiling of patients with non-valvular atrial fibrillation and moderate-to-high risk of stroke not receiving oral anticoagulation in Spain.
Polo García J; Vargas Ortega D; Formiga F; Unzueta I; Fernández de Cabo S; Chaves J
Semergen; 2019 Sep; 45(6):396-405. PubMed ID: 30573367
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with oral anticoagulant prescription status among patients with a new diagnosis of atrial fibrillation.
Manning E; Burns K; Laurie M; Patten L; Ho M; Sandhu A
Clin Cardiol; 2023 Aug; 46(8):937-941. PubMed ID: 37401357
[TBL] [Abstract][Full Text] [Related]
15. Oral anticoagulation after catheter ablation of atrial fibrillation and the associated risk of thromboembolic events and intracranial hemorrhage: A systematic review and meta-analysis.
Romero J; Cerrud-Rodriguez RC; Diaz JC; Rodriguez D; Arshad S; Alviz I; Cerna L; Rios S; Monhanty S; Natale A; Garcia MJ; Di Biase L
J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1250-1257. PubMed ID: 31257677
[TBL] [Abstract][Full Text] [Related]
16. Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.
McGrath ER; Go AS; Chang Y; Borowsky LH; Fang MC; Reynolds K; Singer DE
J Am Geriatr Soc; 2017 Feb; 65(2):241-248. PubMed ID: 28039855
[TBL] [Abstract][Full Text] [Related]
17. Reasons underlying non-adherence to and discontinuation of anticoagulation in secondary stroke prevention among patients with atrial fibrillation.
Gumbinger C; Holstein T; Stock C; Rizos T; Horstmann S; Veltkamp R
Eur Neurol; 2015; 73(3-4):184-91. PubMed ID: 25633474
[TBL] [Abstract][Full Text] [Related]
18. Predictors of oral anticoagulant non-prescription in patients with atrial fibrillation and elevated stroke risk.
Lubitz SA; Khurshid S; Weng LC; Doros G; Keach JW; Gao Q; Gehi AK; Hsu JC; Reynolds MR; Turakhia MP; Maddox TM
Am Heart J; 2018 Jun; 200():24-31. PubMed ID: 29898845
[TBL] [Abstract][Full Text] [Related]
19. Do CHA2 DS2 VASc and HAS-BLED scores influence 'real-world' anticoagulation management in atrial fibrillation? 1556 patient registry from the reference cardiology centre.
Lopatowska P; Tomaszuk-Kazberuk A; Mlodawska E; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S; Musial WJ
Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1297-303. PubMed ID: 26419506
[TBL] [Abstract][Full Text] [Related]
20. Exploring the Quality of Anticoagulant Prescribed for Patients With Atrial Fibrillation at the St John of God Hawkesbury District Health Centre, New South Wales, Australia.
Wertheimer G; Bereznicki LR
J Cardiovasc Pharmacol Ther; 2019 Jan; 24(1):46-53. PubMed ID: 29962220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
